PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Drug Abuse 13,496 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.62
Hearing Loss 30,622 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.60
Carcinoma 433,099 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.54
Carcinoma 433,099 Disease Target CAMK1D 21 1 0.00 -0.98 0.05 0.54
Carcinoma 433,099 Disease Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.54
Eczema 12,327 Disease Disease Cradle Cap 21 3 0.01 -0.93 0.14 0.65
Depression 220,092 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.56
Depression 220,092 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Diaper Rash 155 Disease Disease Cradle Cap 21 3 0.05 -0.92 0.14 0.80
Cancer 1,053,491 Disease Target AMY2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target CAMK1D 21 2 0.00 -0.95 0.10 0.54
Cancer 1,053,491 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Target CAMK2D 21 2 0.00 -0.95 0.10 0.54
Cancer 1,053,491 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Target CAMK2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target DJ-1/PARK7 21 4 0.00 -0.90 0.19 0.55
Cancer 1,053,491 Disease Target Alpha Platelet-Derived Growth Factor Receptor 21 3 0.00 -0.93 0.14 0.55
Parkinsons Disease 124 Disease Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.76
Brain Injury 34,874 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.60
Parkinsonism 13,164 Disease Target DJ-1/PARK7 21 1 0.00 -0.98 0.05 0.62
Ovarian Cancer 33,996 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.60
Ovarian Cancer 33,996 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.60
Prostate Cancer 71,064 Disease Target Alpha Platelet-Derived Growth Factor Receptor 21 3 0.00 -0.93 0.14 0.60
Skin Cancer 11,561 Disease Drug Alefacept (Amevive)- FDA 21 1 0.00 -0.98 0.05 0.62
Skin Cancer 11,561 Disease Drug Amevive (Alefacept)- FDA 21 1 0.00 -0.98 0.05 0.62
Inflammatory Bowel Disease 24,375 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.60
Infection 766,637 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.53
Infection 766,637 Disease Target Protein Fimh 21 5 0.00 -0.87 0.24 0.56
Stroke 146,992 Disease Target CAMK1D 21 1 0.00 -0.98 0.05 0.56
Stroke 146,992 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.56
Influenza 67,933 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.58
Influenza 67,933 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.58
Shock 134,031 Disease Target DJ-1/PARK7 21 2 0.00 -0.95 0.10 0.58
Arthritis 128,324 Disease Drug Alefacept (Amevive)- FDA 21 2 0.00 -0.95 0.10 0.58
Arthritis 128,324 Disease Drug Amevive (Alefacept)- FDA 21 2 0.00 -0.95 0.10 0.58
Respiratory Tract Infections 9,721 Disease Disease Cradle Cap 21 1 0.00 -0.98 0.05 0.63
Major Depressive Disorder 12,517 Disease Target CAMK2D 21 1 0.00 -0.98 0.05 0.62
Cholesterol 182,390 Disease Target CAMK2B 21 1 0.00 -0.98 0.05 0.56
Inflammation 252,734 Disease Target Protein Fimh 21 1 0.00 -0.98 0.05 0.55
Lung Cancer 91,416 Disease Drug Aranesp (Darbepoetin Alfa)- FDA 20 1 0.00 -0.97 0.05 0.57
Scars 12,872 Disease Drug Dracorhodin 20 1 0.00 -0.97 0.05 0.62
Diabetes 332,602 Disease Target BRSK1 20 1 0.00 -0.97 0.05 0.55
Psychiatric Disorder 6,440 Disease Target Cyclooxygenase-3 20 1 0.00 -0.97 0.05 0.64
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
Obesity 138,233 Disease Target BRSK1 20 1 0.00 -0.97 0.05 0.57
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
Carcinoma 433,099 Disease Target BRSK1 20 1 0.00 -0.97 0.05 0.54
Carcinoma 433,099 Disease Drug Ascorbic Acid (Vitamin C)- FDA 20 1 0.00 -0.97 0.05 0.54
Hemorrhage 100,979 Disease Drug Apresoline (Hydralazine)- FDA 20 1 0.00 -0.97 0.05 0.57
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56